5,7-Dichloroimidazo[1,2-a]pyrimidine, 90.0%, 100mg

3-Chloro-4-(1H-pyrazol-1-yl)benzaldehyde, 95.0%, 5g

4,4'-Dimethoxybenzophenone>99.0%(GC)25g

(R)-2-(2-CHLOROPHENYL)PYRROLIDINE, 95.0%, 1g

(Z)-5-(4-iodobenzylidene)-2-thioxothiazolidin-4-one, 98%, 500mg

1-butyl-1H-pyrazol-4-amine, 95.0%, 2g

3-IODO-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER, 95.0%, 5g

Diethyl carbonate, 99.0%, 100g

Ethyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate, 98.0%, 1g

1H-Pyrrole-2-carboxaldehyde, 1-[(4-methylphenyl)sulfonyl]-, 98%, 100g

C-(3-Chloro-5-trifluoromethyl-pyridin-2-yl)-methylamine; compound with acetic acid, 95.0%, 5g

Matraces aforados con tapón de vidrio, clase A Vidrio transparente, 50 ml, 12/21, 2 Pieza(s)

4-chloro-2-fluoro-3'-morpholinomethyl benzophenone, 97.0%, 1g